Literature DB >> 12641515

Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998.

A Newnham1, M J Quinn, P Babb, J Y Kang, A Majeed.   

Abstract

BACKGROUND: The incidence of adenocarcinoma of the oesophagus and gastric cardia has increased in many countries. AIM: To describe the trends in the subsite and morphology of oesophageal and gastric cancer using cancer registry data from 1971 to 1998.
METHODS: We calculated the overall age-standardised incidence in each year; the age-standardised incidence by subsite, by morphology and by subsite and morphology; and the ratio of the rates in men and women in 1971 and 1998.
RESULTS: The incidence of oesophageal adenocarcinoma increased from 1.5 to 7.0 per 100,000 men and from 0.4 to 1.5 per 100,000 women. The incidence of cancer at the cardia also increased, from 2.0 to 5.4 per 100,000 men and from 0.6 to 1.4 per 100,000 women, but the incidence of gastric cancer without a specified subsite decreased markedly from 21.3 to 9.3 per 100,000 men and from 10.7 to 4.2 per 100,000 women.
CONCLUSIONS: Although some of the increase in the incidence of adenocarcinoma of the gastric cardia is probably real, this interpretation is limited by the proportion of cancers without specified subsites or morphologies.

Entities:  

Mesh:

Year:  2003        PMID: 12641515     DOI: 10.1046/j.1365-2036.2003.01521.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  14 in total

1.  Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas.

Authors:  Da-Long Wu; Hui-Xing Yi; Feng-Ying Sui; Xiao-Hong Jiang; Xiao-Ming Jiang; Ying-Ying Zhao
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

2.  Increasing incidence of Barrett's oesophagus: a population-based study.

Authors:  Helen G Coleman; Shivaram Bhat; Liam J Murray; Damian McManus; Anna T Gavin; Brian T Johnston
Journal:  Eur J Epidemiol       Date:  2011-06-14       Impact factor: 8.082

3.  Analysis of mortality rates for gallbladder cancer across the world.

Authors:  D Hariharan; A Saied; H M Kocher
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

4.  Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy.

Authors:  Gary D Mackenzie; Jason M Dunn; C R Selvasekar; C Alexander Mosse; Sally M Thorpe; Marco R Novelli; Stephen G Bown; Laurence B Lovat
Journal:  Lasers Med Sci       Date:  2008-12-05       Impact factor: 3.161

5.  Analysis of mortality rates for pancreatic cancer across the world.

Authors:  D Hariharan; A Saied; H M Kocher
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

6.  Epidemiological investigation of esophageal carcinoma.

Authors:  Hong Zhang; Shao-Hua Chen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

7.  Elastic scattering spectroscopy for detection of cancer risk in Barrett's esophagus: experimental and clinical validation of error removal by orthogonal subtraction for increasing accuracy.

Authors:  Ying Zhu; Tom Fearn; Gary Mackenzie; Ben Clark; Jason M Dunn; Irving J Bigio; Stephen G Bown; Laurence B Lovat
Journal:  J Biomed Opt       Date:  2009 Jul-Aug       Impact factor: 3.170

8.  A randomised controlled trial of ALA vs. Photofrin photodynamic therapy for high-grade dysplasia arising in Barrett's oesophagus.

Authors:  J M Dunn; G D Mackenzie; M R Banks; C A Mosse; R Haidry; S Green; S Thorpe; M Rodriguez-Justo; A Winstanley; M R Novelli; S G Bown; L B Lovat
Journal:  Lasers Med Sci       Date:  2012-06-15       Impact factor: 3.161

9.  Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.

Authors:  Victoria H Coupland; William Allum; Jane M Blazeby; Michael A Mendall; Richard H Hardwick; Karen M Linklater; Henrik Møller; Elizabeth A Davies
Journal:  BMC Cancer       Date:  2012-01-12       Impact factor: 4.430

10.  Survival from cancer of the stomach in England and Wales up to 2001.

Authors:  E Mitry; B Rachet; M J Quinn; N Cooper; M P Coleman
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.